Article Text

Download PDFPDF
Use of far field basilar artery stenting for recurrent middle cerebral artery ischemia
  1. W Lee Titsworth1,
  2. A Cahid Civelek2,
  3. Alex Abou-Chebl3
  1. 1Department of Anatomical Sciences and Neurobiology, University of Louisville School of Medicine, Louisville, Kentucky, USA
  2. 2Department of Radiology, University of Louisville School of Medicine, Louisville, Kentucky, USA
  3. 3Department of Neurology, Division of Interventional Neurology, University of Louisville School of Medicine, Louisville, Kentucky, USA
  1. Correspondence to Dr A Abou-Chebl, Department of Neurology, Division of Interventional Neurology, Room #114, University of Louisville School of Medicine, 500 S Preston St, Louisville, KY 40202, USA; a0abou03{at}louisville.edu

Abstract

Intracranial artery angioplasty and stenting are generally performed for ipsi-territory stroke prevention in stenotic disease; however, few options exist for chronic occlusion of a proximal feeding vessel. In such circumstances intracranial angioplasty and stenting of a neighboring vascular field may improve collateral flow to the territory of the occluded vessel. A case of basilar artery (BA) stenting is presented, performed to improve collateral flow in a man experiencing recurrent middle cerebral artery (MCA) strokes, despite superior temporal artery (STA)–MCA bypass for internal carotid artery occlusion. Following BA stenting, the patient had complete cessation of MCA ischemia and improved cerebrovascular reserve by single photon emission CT. BA stenting was found to be a safe and effective means of improving collateral flow to mitigate recurrent MCA infarctions. Far field interventions should be considered in selected patients who fail other treatments.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Footnotes

  • Competing interests AA is a member of the BMS/Sanofi Speaker's Bureau and has participated in a research trial of intracranial stent sponsored by Micrus Medical Inc.

  • Patient consent Obtained.

  • Provenance and peer review Not commissioned; externally peer reviewed.